ROCKVILLE, Md., Jan. 6, 2016 /PRNewswire/ -- Synthetic
Biologics, Inc. (NYSE MKT: SYN), a clinical stage company focused
on developing therapeutics to protect the gut microbiome, announced
today that Jeff Riley, CEO, is
scheduled to present at the Biotech
Showcase™ 2016 Conference next week in
San Francisco, as follows:
Date: Monday, January 11,
2016
Time: 11:00 a.m. (PT) /
2:00 p.m. (ET)
Location: Parc 55 Wyndham San Francisco Union Square Hotel -
Room: Market Street (3rd Floor)
A live webcast of Synthetic Biologics' presentation may be
accessed by logging onto the internet at
http://edge.media-server.com/m/p/ax9f6zv8. After the presentation,
a replay will be archived and accessible for 90 days at the same
website.
About Synthetic Biologics, Inc.
Synthetic Biologics, Inc. (NYSE MKT: SYN) is a clinical stage
company developing therapeutics to protect the microbiome while
targeting pathogen-specific diseases. The Company's lead candidates
in Phase 2 development include: (1) SYN-004 which is designed to
protect the gut microbiome from the effects of certain commonly
used intravenous (IV) antibiotics for the prevention of C.
difficile infection and antibiotic-associated diarrhea (AAD), and
(2) SYN-010 which is intended to reduce the impact of methane
producing organisms in the gut microbiome to treat an underlying
cause of irritable bowel syndrome with constipation (IBS-C). In
addition, the Company is developing a Phase 2 oral estriol drug for
the treatment of relapsing-remitting multiple sclerosis (MS) and
cognitive dysfunction in MS, and in collaboration with Intrexon
Corporation (NYSE: XON), a preclinical stage monoclonal antibody
for the prevention and treatment of Pertussis and discovery stage
biotherapeutics for the treatment of phenylketonuria (PKU). For
more information, please visit Synthetic Biologics' website at
www.syntheticbiologics.com.
Logo
- http://photos.prnewswire.com/prnh/20160105/319502LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/synthetic-biologics-to-present-at-the-biotech-showcase-2016-conference-300199954.html
SOURCE Synthetic Biologics, Inc.